Nascent Biotech
$0.06
9
+$0+9.33% Thursday 18:48
Statistik
Harga Tertinggi Hari Ini
0.05
Harga Terendah Hari Ini
0.05
52M Tinggi
0.28
52M Rendah
0.03
Volume
115,308
Rata-Rata Volume
148,880
Kap Pasar
7.9M
Rasio P/E
-
Hasil Dividen
-
Dividen
-
Pendapatan
10NovDiharapkan
EPS yang Diharapkan
T/A
EPS Aktual
-0.0012
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti NBIO. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Ayala Pharmaceuticals
ADXS
Kap Pasar851,880
Gritstone Bio
GRTS
Kap Pasar56.31M
Marker Therapeutics
MRKR
Kap Pasar32.21M
PDS Biotechnology
PDSB
Kap Pasar117.82M
SELLAS Life Sciences Group
SLS
Kap Pasar82.99M
Tentang
Agricultural Commodities/Milling
Process Industries
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
Show more...
CEO
Negara
US
ISIN
US63108Q1013